10/11/09 Urgent 'Swine Flu' update

Editor: This is a new improved 'short course' others can modify for media and broader distribution. Fortunately professional & public skepticism and resistance is growing, but truthful information, necessary to make informed decisions, is suppressed in u.s. media

Study prompts provinces to rethink flu plan
September 30, 2009, Globe and Mail

A “perplexing” Canadian study linking H1N1 to seasonal flu shots is throwing national influenza plans into disarray and testing public faith in the government agencies responsible for protecting the nation's health. Distributed for peer review last week, the study confounded infectious-disease experts in suggesting that people vaccinated against seasonal flu are twice as likely to catch swine flu. The paper has since convinced several provincial health agencies to announce hasty suspensions of seasonal flu vaccinations, long-held fixtures of public-health planning. “It has confused things very badly,” said Dr. Ethan Rubinstein, head of adult infectious diseases at the University of Manitoba. “And it has certainly cost us credibility from the public because of conflicting recommendations. Until last week, there had always been much encouragement to get the seasonal flu vaccine.” On Sunday Quebec joined Alberta, Saskatchewan, Ontario and Nova Scotia in suspending seasonal flu shots for anyone under 65 years of age. Quebec's Health Ministry announced it would postpone vaccinations until January. B.C. is expected to announce a similar suspension during a press conference Monday morning. Other provinces, including Manitoba, are still pondering a response to the research. Dr. Rubinstein, who has read the study, said it appears sound. “There are a large number of authors, all of them excellent and credible researchers,” he said. “And the sample size is very large – 12 or 13 million people taken from the central reporting systems in three provinces. The research is solid.”

Health Care Workers Protest Mandatory H1N1 Vaccination

Most parents say they'll skip kids' H1N1 shot
In a poll of 1,678 U.S. parents conducted by the University of Michigan's C.S. Mott Children's Hospital, only four in 10 parents responding said they would get their children immunized against the H1N1 virus, even as 54 percent indicated they will get their kids vaccinated against regular seasonal flu. Germ-spreading schoolchildren are expected to be the focus of a massive U.S. vaccination campaign against the H1N1 flu. But if their parents are hearing the rallying cry to have their kids vaccinated, they're not buying it, says a new national survey[...]
Related: State lifts limit on mercury preservative in swine-flu shots

Drug to combat swine flu leaves '1,000 patients in suffering'
By Steve Connor, Science editor
Officials insist Tamiflu is safe as reports of side effects continue to rise[...]

just a few already-know and covered-up tips of a toxic iceberg...
US reviews risks of Tamiflu after 12 children die -"18 Nov 2005 .. safety of Tamiflu questioned for the second time in a week following reports that it has been linked to the ..." www.independent.co.uk/news/world/americas/us-reviews-risks-of-tamiflu-af...
Tamiflu, Relenza Need New Warnings, U.S. Panel Says..."27 Nov 2007 ... Tamiflu added a precaution about these risks last November, and regulators have identified similar reports in Relenza patients since then. ..."www.bloomberg.com/apps/news?pid=20601101&sid=ack89tMid6.A


The CDC recommends Tamiflu for prevention and treatment of swine flu, as they did with the avian flu several years ago. Yet at the height of the avian flu scare, European researchers conducted a review of numerous studies of of anti-viral medications, which was then published in the prestigious medical journal Lancet on Jan. 19, 2006. According to this review of 51 randomized controlled trials, Tamiflu was useless against the avian flu and many other flus. Contrary to the CDC, their recommendation was not to use Tamiflu. What about now?

The CDC website states , "CDC recommends the use of oseltamivir or zanamivir for the treatment and/or prevention of infection with these swine influenza viruses." Oseltamivir is Tamiflu, the same drug recommended for the avian flu only a few years ago. Yet Tamiflu has been shown numerous times to be ineffective against avian flu, which in case you haven't noticed, never came close to being a pandemic....

At the height of the avian flu scare, European researchers conducted a review of numerous studies of anti-viral medications, which was then published in the prestigious medical journal Lancet on Jan. 19, 2006. According to this review of 51 randomized controlled trials, Tamiflu was useless against the avian flu and many other flus. As reported in Time magazine and the Wall Street Journal , the study's authors found no "credible evidence" that Tamiflu works against avian flu. Contrary to the CDC, their recommendation was not to use Tamiflu.

As the media was spreading fear about the avian flu around the world, the CDC came out with the Tamiflu recommendation, yet provided little evidence of its effectiveness. Only later was the recommendation seriously questioned. How could the CDC be so confident in its recommendation without significant research? How can health officials claim Tamiflu is effective with any certainty now, when the current rash of swine flu cases were discovered such a short time ago?

Tamiflu: Resistant Strains, Side Effects, and Expiration Date
CBS and Associated Press reported on Dec. 12, 2005 that some avian flu victims died after developing resistance to Tamiflu (...)
And there were the deaths not from the flu or drug resistant strains, but from the side effects of Tamiflu. According to a report in Australia's respected Sydney Morning Herald on March 1, 2007, there were 18 juvenile fatalities linked to side effects of Tamiflu in 17 months. And though the U.S. media largely failed to report it, Japan banned Tamiflu for teenagers that same month. According the the official Tamiflu website , "people with the flu, particularly children and adolescents, may be at an increased risk of self injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior." .
According to a Feb. 2, 2007 New York Times report , the U.S. government at the time was creating a $1.4 billion stockpile of Tamiflu, while admitting that "it is useful only when taken within the first 48 hours, and Tamiflu-resistant strains of the flu have already been found in Vietnam and in Egypt."[...]

Flu victim exhumed after 85 years
Phyllis Burns was 20 when she died. Scientists are preparing to exhume the body of a woman who died of flu 85 years ago to find out how the virus killed millions across Europe....

Killer flu recreated in the lab
Scientists have shown that tiny changes to modern flu viruses could render them as deadly as the 1918 strain which killed millions. A US team added two genes from a sample of the 1918 virus to a modern strain known to have no effect on mice. Animals exposed to this composite were dying within days of symptoms similar to those found in human victims of the 1918 pandemic. ...

New flu resembles feared 1918 virus, study finds
Jul 13, 2009
"There is a misunderstanding about this virus," he said in a statement. "There is clear evidence the virus is different than seasonal influenza." Writing in the journal Nature, Kawaoka and colleagues noted that the ability to infect the lungs is a characteristic of other pandemic viruses, especially the 1918 virus, which is estimated to have killed between 40 million and 100 million people....
Other tests showed the virus could be controlled by the antiviral drugs Relenza, made by GlaxoSmithKline and Tamiflu, made by Roche AG the researchers said...Companies working on an H1N1 vaccine include Sanofi-Aventis, Novartis AG, Baxter International Inc, GlaxoSmithKline and nasal spray maker MedImmune, now part of AstraZeneca....

Inventory Uncovers 9,200 More Pathogens Missing
An inventory of potentially deadly pathogens at Fort Detrick's infectious disease laboratory found more than 9,000 vials that had not been accounted for, Army officials said yesterday, raising concerns that officials wouldn't know whether dangerous toxins were missing. After four months of searching about 335 freezers and refrigerators at the U.S. Army Medical Research Institute of Infectious Diseases in Frederick, investigators found 9,220 samples that hadn't been included in a database of about 66,000 items listed as of February, said Col. Mark Kortepeter, the institute's deputy commander. The vials contained some dangerous pathogens, among them the Ebola virus, anthrax bacteria and botulinum toxin, and less lethal agents such as Venezuelan equine encephalitis virus and the bacterium that causes tularemia. ...

Swine flu test results are unreliable, WHO warns
June 10, 2009
The rRT-PCR testing method was developed by the global pharmaceutical giant Roche - the company that also owns the rights to Tamiflu, one of just two anti-viral drugs used to treat the virus.

Vaccines Far More Deadly Than The Swine Flu
Institute of Science in Society, Dr. Mae-Wan Ho and Prof. Joe Cummins
This report submitted to Sir Liam Donaldson, Chief Medical Officer of the UK, and to the US Food and Drugs Administration
Please circulate widely to your elected representatives, wherever you are

FDA approves emergency rules for antiviral drugs
The Food and Drug Administration has issued emergency guidance that allows certain antiviral drugs to be used in a broader range of the population in case mass dosing is needed to deal with a widespread swine flu outbreak...Monday, the FDA said it issued emergency guidance to allow Tamiflu to treat and prevent flu in children under 1 and to provide doses other than originally approved in children over 1. The drugs may be distributed to larger segments of the population without complying with the approved label requirements, the FDA said.

Legal immunity set for swine flu vaccine makers
July 20, 2009, MSNBC/Associated Press
The last time the government embarked on a major vaccine campaign against a new swine flu, thousands filed claims contending they suffered side effects from the shots. This time, the government has already taken steps to head that off. Vaccine makers and federal officials will be immune from lawsuits that result from any new swine flu vaccine, under a document signed by Secretary of Health and Human Services Kathleen Sebelius, government health officials said Friday. Since the 1980s, the government has protected vaccine makers against lawsuits over the use of childhood vaccines. The document signed by Sebelius last month grants immunity to those making a swine flu vaccine, under the provisions of a 2006 law for public health emergencies. It allows for a compensation fund, if needed. The government takes such steps to encourage drug companies to make vaccines, and it's worked. Federal officials have contracted with five manufacturers to make a swine flu vaccine. The last time the government faced a new swine flu virus was in 1976. Federal officials vaccinated 40 million Americans during a national campaign. A pandemic never materialized, but thousands who got the shots filed injury claims, saying they suffered a paralyzing condition called Guillain-Barre Syndrome or other side effects.

Ulterior motives? Sarkozy’s Secret Plan for Mandatory Swine Flu Vaccination
by F. William Engdahl
The French report comes just after the State of Massachusetts State Senate passed a mandatory vaccination bill that authorizes mandatory vaccination against purported H1N1 Swine Flu. In New York State the state hospital planning authority is debating making mandatory annual vaccination against flu of all public health employees, despite the fact that no approved vaccine for H1N1 exists. More and more it is beginning to appear that the scare about pandemic from flying birds or flying pigs is an excuse to justify mandatory vaccination with substances whose harmful side effects are demonstrably worse than any flu they should guard us against.
Novavax, a US pharmaceutical company based in Rockville, Maryland, conveniently just announced it is developing a vaccine for H1N1 based on “virus-like particles” that contain three key proteins of the flu virus without the genes required for replication. The vaccine is produced by techniques of genetic modification of organisms or GMO. The announcement came within days of the company announcing losses for the fiscal year of $36 million.
The drug Tamiflu which is officially recommended by the WHO as treatment to ‘ameliorate’ the symptoms of possible Swine Flu or H1N1 Influenza A as it has been renamed, is itself highly toxic. Health Canada informed Canadians of international reports of hallucinations and abnormal behaviour, including self harm, in patients taking the antiviral drug Tamiflu. In some cases death was the result and severe lung complications are widely reported associated with Tamiflu...
Mandatory vaccination with drugs whose side effects are unknown because they have not been rigorously and independently tested begins to smack of the kind of inhuman mass human experiments carried out in the United States with mentally retarded, prisoners and other disadvantaged people or in Germany during the 1930’s.

Now legal immunity for swine flu vaccine makers.
By F. William Engdahl
Global Research, July 19, 2009
The US Secretary of Health and Human Services, Kathleen Sebelius, has just signed a decree granting vaccine makers total legal immunity from any lawsuits that result from any new “Swine Flu” vaccine. Moreover, the $7 billion US Government fast-track program to rush vaccines onto the market in time for the Autumn flu season is being done without even normal safety testing. Is there another agenda at work in the official WHO hysteria campaign to declare so-called H1N1 a pandemic virus threat?

First and foremost, neither the WHO nor the CDC or any other scientific body has demonstrated required scientific proof for the existence of the alleged H1N1 Influenza A new virus, a proof which requires such a virus to be scientifically isolated, characterized and photographed with an electron microscope—the scientifically accepted standard procedure. Yet it is being used as the basis for declaring a global “pandemic” threat.

The current official panic campaign over alleged Swine Flu danger is rapidly taking on the dimensions of a George Orwell science fiction novel. The document signed by Sebelius grants immunity to those making a swine flu vaccine, under the provisions of a 2006 law for public health emergencies.
Curiously enough, a full year before any reported case of the current alleged H1N1, the major pharmaceutical company, Baxter, filed for a patent for H1N1 vaccine: Baxter Vaccine Patent Application US 2009/0060950 A1. Their application states, “the composition or vaccine comprises more than one antigen.....such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes."

The application further states, “Suitable adjuvants can be selected from mineral gels, aluminium hydroxide, surface active substances, lysolecithin, pluronic polyols, polyanions or oil emulsions such as water in oil or oil in water, or a combination thereof. Of course the selection of the adjuvant depends on the intended use. E.g. toxicity may depend on the destined subject organism and can vary from no toxicity to high toxicity."

With no legal liability, could it be that Baxter is preparing to sell hundreds of millions of doses containing highly toxic aluminium hydroxide as adjuvant? Perhaps it is time to demand that all leading officials of WHO, SAGE and CDC, the US Obama Administration Cabinet officials all step up and be first to take the full dose of H1N1 vaccines being unleashed on the public. We should add to the list of suggested first receivers all members of Congress who voted the $7 billion H1N1 emergency funds and who have gone along with the declaration of pharmaceutical company immunity from subsequent prosecution for damage from their products. They not the general population should be the first human Guinea Pigs to take the new vaccine shots. We can then observe results. The same should apply as well for other national governments and relevant health agencies demanding its citizens take the H1N1 vaccine from GlaxoSmithKline or Baxter, to see if it is really safe.

WHO stopped even tracking H1N1. Another indication that the world is being taken for colossal suckers in the entire WHO Swine Flu scare scenario, the WHO itself, the world body entrusted to monitor outbreaks of so-called pandemics or even epidemics worldwide, has just decided to stop tracking Swine Flu (or H1N1 Influenza A as they prefer to name it now, so as not to offend Smithfield Foods and other industrialized pig CAFO producers). The World Health Organization in a “briefing note” posted on their Web site posted the baffling notice that they would no longer track outbreaks of H1N1.
The Atlanta CDC also agreed to the WHO count drop. Dr. Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, admits that the existing tests to confirm H1N1 Influenza A are not even certain, but rather hit-or-miss. “Bad measures can be worse than no measures at all,” he stated. So the WHO has decided to drop tests that anyway did not give a scientific picture of who had H1N1 or not, and as well they have decided to drop counting any test results or cases of H1n1 around the world with the comment that “we can assume almost all cases are H1N1 Swine Flu.” This is supposed to be science on which basis we are told to vaccinate our young?

By Executive Order 13295 of April 4, 2003: the government has the authority to establish "regulations providing for the apprehension, detention, or conditional release of individuals to prevent the introduction, transmission, or spread of suspected communicable diseases," including diseases at that time "not yet isolated or named."

Military Poised to Help FEMA Battle Swine Flu Outbreak
Pentagon prepares to help the Federal Emergency Management Agency tackle a potential outbreak of the H1N1 virus this fall.

Killer flu recreated in the lab
Scientists have shown that tiny changes to modern flu viruses could render them as deadly as the 1918 strain which killed millions. A US team added two genes from a sample of the 1918 virus to a modern strain known to have no effect on mice. Animals exposed to this composite were dying within days of symptoms similar to those found in human victims of the 1918 pandemic.
The research is published in the journal Nature. The work of the US team, lead by Dr Yoshihiro Kawaoka of the University of Wisconsin, was carried out under the tightest security. Experts focused on two genes thought to play a key role in the infection process. One controls production of a spike-like molecule called haemagglutinin (HA), believed to be used by the flu virus to attach itself to the cells it is about to infect.
Previous research published earlier this year in the journal Science identified the HA gene as being the crucial element which made the 1918 virus so deadly - and the latest work appears to confirm this. Post mortems on mice injected in the nose with the composite virus showed that it had rampaged through their lungs, producing inflammation and haemorrhaging.
The researchers stress the experiment is conclusive for lab mice, and not humans. But they say that their work may lead to better ways to assess the potential danger of emerging flu viruses.
Writing in Nature, the researchers say: "Once the properties of the (1918) HA gene that gave rise to its lethal infectivity are better understood, it should be possible to devise effective control measures and to improve global surveillance networks for influenza viruses that pose the greatest threat to humans as well as other animal species."

Scientists believe the 1918 virus leapt to humans by mutating from bird flu, possibly after passing through pigs, which are able to harbour both human and avian viruses and thus allow them to swap genes as the viruses reproduce. For that reason, experts are deeply concerned that the avian flu that has broken out in poultry flocks in parts of south-east Asia may acquire genes that will make it highly infectious as well as lethal for humans....

Professor John Oxford, an expert in virology at Queen Mary College London, told BBC News Online the latest research underlined just what a threat all flu viruses potentially posed. He said: "It is not a big difference at all between a virus that kills 15m people and one that does not kill anyone at all. "The lesson is not to be complacent about anything to do with flu. Every flu virus must be carrying baggage that could potentially harm us, and we would be well advised not to ignore them."

The 1918 "Spanish" flu pandemic is estimated to have infected up to one billion people - half the world's population at the time. The virus killed more people than any other single outbreak of disease, surpassing even the Black Death of the Middle Ages. Although it probably originated in the Far East, it was dubbed "Spanish" flu because the press in Spain - not being involved in World War I - were the first to report extensively on its impact.The virus caused three waves of disease. The second of these, between September and December 1918, resulting in the heaviest loss of life.
It is thought that the virus may have played a role in ending World War I as soldiers were too sick to fight, and by that stage more men on both sides died of flu than were killed by weapons.
Although most people who were infected with the virus recovered within a week following bed rest, some died within 24 hours of infection.
http://news.bbc.co.uk/go/pr/fr/-/2/hi/health/3719990.stm Published: 2004/10/07

excerpted from Ineffectiveness and Dangers of Flu Shots
by Stephen Lendman

...More Disclaimers about Flu Vaccine Effectiveness and the Truth about Their Dangers
First the worst news. Annual flu shots may induce one or more of the above-mentioned annoying to life-threatening autoimmune diseases, including severe allergies, diabetes, and the Guillan-Barre Syndrome (GBS) nerve disorder that causes progressive muscle weakness, paralysis, and at times death. They can also cause encephalitis, an acute inflammation of the brain; various neurological disorders; and thrombocytopenia, a serious blood disorder.

Now the bad news. Annual flu shots don’t work, except to enhance producer profits, which is why the industry, complicit regulatory bodies, and the media tell unsuspecting people to take them.
Each year, government health agencies guess which viral strain(s) are most worrisome. Usually they’re wrong. For example, New York Times writer Lawrence Altman headlined his January 15, 2004 article, “Vaccine Is Said to Fail to Protect Against Flu Strain” in reporting that the CDC said its most recent recommended flu vaccine had “no or low effectiveness” against that season’s Fujian threat, based on study results from its first ever health providers survey. Other studies report similar findings, and so do reliable scientists from their research.

The Lancet reported that a 2008 study on “immunocompetent elderly people aged 65-94 years enrolled in Group Health (a health maintenance organisation) during 2000, 2001, and 2002? found that “influenza vaccination was not associated with a reduced risk of community-acquired pneumonia during the influenza season.” Influenza predisposes individuals to contracting pneumonia... the prestigious medical journal concluded that “The effect of influenza vaccination on the risk of pneumonia in elderly people during the influenza seasons might be less than previously estimated.” Yet doctors keep recommending them based on misleading industry and government information.

In October 2007, the National Institute of Allergy and Infectious Diseases, National Institutes of Health reported on the “mortality benefits of influenza vaccination in elderly people: an ongoing controversy” and concluded: “frailty selection bias and use of non-specific endpoints such as all-cause mortality have led cohort studies to greatly exaggerate vaccine benefits. The remaining evidence base is currently insufficient to indicate the magnitude of the mortality benefit, if any, that elderly people derive from the vaccination programme.”

On May 1, 2003, the New England Journal of Medicine reported on the largest ever study to determine the effectiveness of pneumococcal pneumonia vaccine inoculations – based on medical data for 47,365 people aged 65 or older from 1998-2001. It found no significant association between vaccination and a reduced pneumonia risk in concluding: “alternative strategies are needed to prevent nonbacteremic pneumonia, which is a more common manifestation of pneumococcal infection in elderly persons.” In other words, flu shots don’t work, so why take them.

An October 2008 published study in the Archives of Pediatric & Adolescent Medicine had similar conclusions based on doctor visits during the two most recent flu seasons. It reported:
“In 2 seasons with suboptimal antigenic match between vaccines and circulating strains, we could not demonstrate VE in preventing influenza-related inpatient/ED or outpatient visits in children younger than 5 years. Further study is needed during years with good vaccine match.”

In September 2008, the American Journal of Respiratory and Critical Care Medicine reported that the Department of Public Health Sciences, School of Public Health, University of Alberta concluded as follows from “clinical, laboratory, and functional data” collected on 1,813 adults “with community-acquired pneumonia admitted to six hospitals outside of influenza season” in Alberta: “mortality benefits of influenza vaccination” are “overestimated” even though the population inoculated increased from 15% in 1980 to 65% in 2008.

In the October 2006 British Medical Journal, Dr. Tom Jefferson wrote about “Influenza vaccination: policy versus evidence” and concluded: Evidence from systematic reviews shows that inactivated vaccines have little or no effect on the effects measured. (In addition), Little comparative evidence exists on the safety of these vaccines…. The optimistic and confident tone of some predictions of viral circulation and the impact of inactivated vaccines, which are at odds with the evidence, is striking. The reasons are probably complex and may involve a messy blend of truth and conflicts of interest making it difficult to separate factual disputes from value disputes.

In other words, influenza vaccination programs are ineffective and worthless. They’re also dangerous.
In 2006, the Cochrane Database of Systematic Reviews reported on an Oxford University, Institute of Health Sciences examination of “Vaccines for preventing influenza in healthy children” and concluded from the results of 51 studies involving 263,987 subjects aged 23 months to six years that vaccines are little more effective than placebos. It added that:
“If immunisation in children is to be recommended as a public-health policy, large-scale studies assessing important outcomes and directly comparing vaccine types are urgently needed.”

FDA-Approved Swine Flu (H1N1) Vaccines
On September 15, the FDA: "announced today that it has approved four vaccines against the 2009 H1N1 influenza virus. The vaccines will be distributed nationally after the initial lots become available, which is expected to be within the next four weeks…. Based on preliminary data from adults participating in multiple clinical trials, the 2009 H1N1 vaccines induce a robust immune response in most health adults eight to 10 days after a single dose, as occurs with the seasonal influenza vaccine." The FDA warned that “People with severe or life-threatening allergies to chicken eggs, or to any other substance in the vaccine, should not be vaccinated.” ...

Novartis’ version contains its proprietary squalene adjuvant MF59, linked to annoying to potentially deadly autoimmune and other diseases, including paralysis, autism, Alzheimer’s disease, and Gulf War Syndrome. Glaxo’s ASO3 poses the same risks and will be available in America through CSL Ltd.’s vaccine. Squalene in vaccines has been secretly used for years, but according to Dr. Rima Laibow, Medical Director of the Natural Solutions Foundation: “Never before has (it) been (officially) approved for use in a drug in the United States. But once before, when it was allowed in certain military vaccines, more than 60,000 soldiers were hospitalized (by what became) known as ‘Gulf War Syndrome.’ (In Doe v. Rumsfeld, a) Federal Court in 2004, forbade its involuntary use by United States troops. “This new (Swine Flu) vaccine has, literally, 1,000,000 time more squalene than the experimental military vaccine, known as ‘Vaccine A.’ The attempt to rush this dangerous vaccine into the bodies of the public without safety testing is a violation of US law, regulation and medical ethics and must be condemned.” Glaxo (GSK) will distribute CSL Ltd.’s vaccine with its own proprietary high potency squalene adjuvant MPL (monophosphoryl lipid A) system ASO3 that exponentially enhances its dangers as Dr. Laibow explained. ...

September 29, Wall Street Journal writers Jonathan Rockoff and Peter Loftus explained the industry believes vaccines: "...will become an increasingly important source of growth to replace aging blockbusters that are poised to lose patent protection. Vaccine sales are growing faster than sales of other prescription medicines and are largely immune to the generic competition that is already cost drug makers billions of dollars in revenues on their top-selling treatments. Moreover, government agencies both in the US and around the world are increasingly reliable buyers of vaccines as they seek to stockpile medicines that could help protect the public in case of a major flu outbreak..."...
Since most governments sacrifice human health for business profits, who are the guardians to protect us from the coming pathogenic onslaught that may weaken or destroy the immune systems of millions of unsuspecting people, and likely sterilize and/or kill them. Something to consider before submitting to dangerous vaccines that everyone has a legal, ethical and for many a medical right to refuse.
Stephen Lendman lives in Chicago. Contact him at: lendmanstephen@sbcglobal.net. Also visit his blog site http://www.sjlendman.blogspot.com/

Swine Flu Vaccine: Will We Have A Choice?
by Barbara Loe Fisher , President of the National Vaccine Information Center ...
As Department of Homeland Security officials are declaring that any disease outbreak is a matter of homeland security [26][27] <#_edn26> ; as Department of Defense officials are defining public demonstrations as “low level terrorism;” [28] <#_edn28> as CDC officials make plans to re-route airplanes to designated airports with quarantine centers to screen all passengers for signs of swine flu [29] <#_edn29> ; and as fast tracked experimental pandemic flu vaccines are being created to be given to American children first, it is time for all of us – whether we are public health officials addressing what we believe is a true public health emergency or whether we are ordinary citizens simply trying to protect our health and the health of our children - to act in rational and responsible ways.
Barbara Loe Fisher , President of the National Vaccine Information Center , 6/18/09
Note: originally published on the NVIC website . A video of this message is available here .

(all emphases added)

2005 Senate panel backs special vaccine agency
By Andrew Bridges, A
December 2, 2005
WASHINGTON -- By creating a federal agency shielded from public scrutiny, some lawmakers think they can speed the development and testing of new drugs and vaccines needed to respond to a bioterrorist attack or super-flu pandemic. The proposed Biomedical Advanced Research and Development Agency, or BARDA, would be exempt from long-standing open records and meetings laws that apply to most government departments, according to legislation S. 1873 approved Oct. 18 by the Senate health committee. Those exemptions would streamline the development process, safeguard national security and protect the proprietary interests of drug companies, say backers of the bill. The legislation also proposes giving manufacturers immunity from liability in exchange for their participation in the public-private effort.... The agency would provide the funding for development of treatments and vaccines to protect the United States from natural pandemics as well as chemical, biological and radiological agents.
The proposed law comes amid growing concern about pandemics and the government's ability to meet such threats. For instance, the United State needs another three to five years to develop the manufacturing capacity to produce 300 million doses of flu vaccine, Health and Human Services Secretary Mike Leavitt said Sunday on NBC's "Meet the Press."...
The agency would be exempt from the Freedom of Information and Federal Advisory Committee acts, both considered crucial for monitoring government accountability....

ANALYSIS-Mexico flu outbreak could add to economic pain
Mexico's economy has been battered by a U.S. recession that hit the country's export-dependent manufacturing sector hard... Analysts polled by the central bank at the end of March predicted Mexico's economy would shrink 3.3 percent this year. http://www.alertnet.org/thenews/newsdesk/N24446037.htm

Flu heightens Mexico’s economic sickness
Reliance on exports has left country short of options. Even before the H1N1 swine flu brought much of Mexico to a standstill, its economy faced the worst slump since the 1930s....
“This was already an extremely serious situation,” said Rogelio Ramírez de la O, director of Mexico’s Ecanal consultancy. The roots of Mexico’s crisis lie in its reliance on exports to the US to generate a fifth of GDP. The country is discovering the dark side of the NAFTA free-trade accord with the Anglo-Saxons, which has broken the old model of economic nationalism – or “import substitution” – pursued for nearly 70 years by the Institutional Revolutionary Party. “They put all their eggs in one basket by relying so much on the US,” said Luis Carlos Nino, Latin America strategist at Capital Economics. A belt of plants in north Mexico that supply the US auto, aerospace, plastics, and electronics industries has been ravaged. http://freerepublic.com/focus/f-news/2241828/posts

California Cases Suggest Border Origin
SACRAMENTO, Calif. -- Doctors tracking swine flu in this state are investigating a new theory: What if it didn't originate in Mexico but instead had been floating around the border region for months Growing evidence in California suggests that early flu cases had no apparent origin in Mexico.... The first case discovered in California was a 10-year-old boy in San Diego County, who fell ill with a fever March 30. [...] http://online.wsj.com/article/SB124113696409275445.html

Swine flu broke out in California: CDC
03 May 2009

Biotechnology Company, Replikins Ltd., Provided Advance Warning in April 2008 of Mexican H1N1 'Swine Flu' Virus Outbreak

Roche Exec Warns of Flu Pandemic
Avian flu threat very real
April 21, 2008
George Abercrombie, head of Roche’s North American operations, says an avian flu pandemic still threatens the world, and discusses access to Roche’s drug Tamiflu, the main flu antidote

What a flu pandemic could cost the world
"In 2006, we estimated the likely global economic consequences of an influenza ... minor flu outbreak in Mexico City can send markets reeling in Tokyo. ..."
In 2006, we estimated the likely global economic consequences of an influenza pandemic using several epidemic scenarios. The study began with a multi-country, multi-sector, dynamic model capable of describing the trade and financial linkages between and within economies. We then fed the model with a series of shocks meant to simulate the effect of pandemic: a decreased labor force, increased business costs, a shift in consumer preferences due to social distancing, and changes to risk premiums. We took into account the geography of each region and the strength of its health system. Labor supply shocks varied depending on the infection rate and mortality in a given country.... The mild scenario, estimated to cost the world 1.4 million lives, reduces total output by nearly 1 percent or approximately $330 billion (in constant 2006 prices) during the first year. In our model, as the scale of the pandemic increases, so do the economic costs. A massive global economic slowdown occurs in the next-worst scenario, with more than 142 million people killed and some output in economies in the developing world shrinking by half. The loss in output in this scenario could reach $4.4 trillion, 12.6 percent of global GDP in the first year. Of course, the composition of the slowdown would differ sharply across countries, with a major shift of global capital from the affected economies to the less-affected safe havens of North America and Europe.... Wealth and income effects are larger in developing countries, and the contraction of demand is therefore much larger than in Europe and North America (Japan is caught in the middle). The destructive cycle feeds itself; Worse epidemiological outcomes in poorer countries perversely send much-needed capital flowing out and into industrialized economies. This exacerbates the current-account positions of the receiving countries and puts downward pressure on developing-country exchange rates. In essence, entire developing markets could become junk assets....
So far, our real-world swine flu pandemic appears to be less severe than the dire scenarios used in our modeling. But even now, the global economy is seeing some signs of capital retreat. The Mexican peso, for example, has taken a hit. And just five days after news of the outbreak, it looked likely that Mexico's government would have to tap its $47 billion credit line with the International Monetary Fund. http://experts.foreignpolicy.com/posts/2009/04/28/what_a_flu_pandemic_co...
FOREIGN POLICY is published by the Slate Group, a division of Washingtonpost.Newsweek Interactive, LLC.

ANALYSIS-Mexico flu outbreak could add to economic pain
Mexico's economy has been battered by a U.S. recession that hit the country's export-dependent manufacturing sector hard...Analysts polled by the central bank at the end of March predicted Mexico's economy would shrink 3.3 percent this year. http://www.alertnet.org/thenews/newsdesk/N24446037.htm

2008 U.S. Plans for Mexico's Collapse
JFCOM's "Joint Operating Environment" (JOE) document, with a forward by JFCOM's chief, U.S. Marine Corps Four-Star General James Mattis, [who] also heads NATO's Allied Command Transformation, drafted by a team of officers and civilians he selected, was signed in mid-November 2008 and posted on the Pentagon's Web site. It has generated protests by the governments of Mexico - whose potential collapse is depicted as a grave threat to U.S. national security[...]

Homeland Security News

Swine Flu – U.S. Declares Public Health Emergency
April 26, 2009
Homeland Security Secretary Janet Napolitano called the United States’ emergency declaration “standard operating procedure,” and said she would rather call it a “declaration of emergency preparedness.” “It’s like declaring one for a hurricane,” she said. “It means we can release funds and take other measures. The hurricane may not actually hit.”
The emergency declaration in the United States lets the government free more money for antiviral drugs and give some previously unapproved tests and drugs to children. One-quarter of the national stockpile of 50 million courses of antiflu drugs will be released [...]

D.C. Area Officials Coordinate Flu Fight Planners Use Post-Sept. 11 Response To Cut Through Jurisdictional Jumble
By Michael Laris Washington Post Staff Writer
Wednesday, September 2, 2009
Top officials from Maryland, Virginia and the District met Tuesday to coordinate plans for fighting the swine flu, taking advantage of a structure set up after the Sept. 11, 2001, terrorist attacks to try to sharpen the region's response to outbreaks expected this fall. The governors of Maryland and Virginia joined D.C. Mayor Adrian M. Fenty (D) and Homeland Security Secretary Janet Napolitano on a day when President Obama said "every American has a role to play in responding to this virus."

A-H1N1 Swine Flu Likely Originated in US Lab
By William Sutherland
... The evidence for this scenario is compelling:
* Prior to the A/H1N1 outbreak, The Institute for Molecular Virology (IMV) located in Bock Labs (administered by the University of Wisconsin-Madison) had been involved in a transmission capability study for vaccine production. This study involved reverse genetic engineering of a tissue specimen that had been extracted from a deceased Intuit woman who had succumbed to Spanish influenza that had killed up to 50 million people during the 1918-19 pandemic ...
* Samples of the new A/H1N1 virus were already present at the CDC prior to receipt of Mexican specimens. Per CDC virologist Ruben Donis in an interview conducted by Science Direct (published April 29, 2009) - the CDC had completed sequencing of the novel A/H1N1 strain two weeks earlier or by April 15, 2009 - three days before Mexican officials shipped swab samples to its Atlanta headquarters for testing.... [....]

Biological Warfare: Genetically-Engineered Weapons Cannot Be Excluded
By K.P. Kavanaugh
It has long been rumored that modern biological weapons could be designed to attack specific vulnerabilities of particular ethnic groups. Early in the development of the US offensive biological weapons program Colonel Creasey, Chief of Research and Engineering of the US Chemical Corps, suggested that agents may be selected because of known susceptibility of the target population. This shows that the differential susceptibility of different populations to various diseases had been considered at that time and, according to scientists at Defense Advance Research Projects Agency (DARPA), is continuing today....
Nor is it essential to focus on the genetic constitution of a particular group in order to attack it in an ethnic specific way. Vaccination of the attacker against the intended biological agent would give specificity if the target population was not vaccinated. Attacking a particular population with lethal toxins could achieve the same effect. Equally clearly, attacking a principal food source of one side which the other side did not consume (as an example, swine induced diseases are being studied by the US Department of Defense in this area) could produce a specific attack on a designated population....

This article appeared in the London Times, November 1998
Research into "ethnic bombs" is creation of biohazard at the highest level... fulfillment of every worst fear raised by research related to the Human Genome Diversity Project.

ISRAEL is working on a biological weapon that would harm Arabs but not Jews, according to Israeli military and western intelligence sources. The weapon, targeting victims by ethnic origin, is seen as Israel's response to Iraq's threat of chemical and biological attacks... In developing their "ethno-bomb", Israeli scientists are trying to exploit medical advances by identifying distinctive genes carried by some Arabs, then create a genetically modified bacterium or virus. The intention is to use the ability of viruses and certain bacteria to alter the DNA inside their host's living cells. The scientists are trying to engineer deadly micro-organisms that attack only those bearing the distinctive genes. The programme is based at the biological institute in Nes Tziyona, the main research facility for Israel's clandestine arsenal of chemical and biological weapons. A scientist there said the task was hugely complicated because both Arabs and Jews are of semitic origin. But he added: "They have, however, succeeded in pinpointing a particular characteristic in the genetic profile of certain Arab communities, particularly the Iraqi people." The disease could be spread by spraying the organisms into the air or putting them in water supplies...

Dr Daan Goosen, head of a South African chemical and biological warfare plant, said his team was ordered in the 1980s to develop a "pigmentation weapon" to target only black people. He said the team discussed spreading a disease in beer, maize or even vaccinations but never managed to develop one. However, a confidential Pentagon report warned last year that biological agents could be genetically engineered to produce new lethal weapons. William Cohen, the American defence secretary, revealed that he had received reports of countries working to create "certain types of pathogens that would be ethnic-specific". A senior western intelligence source confirmed last week that Israel was one of the countries Cohen had in mind.

The "ethno-bomb" claims have been given further credence in Foreign Report, a Jane's publication that closely monitors security and defence matters. It reports unnamed South African sources as saying Israeli scientists have used some of the South African research in trying to develop an "ethnic bullet" against Arabs. It also says Israelis discovered aspects of the Arab genetic make-up by researching on "Jews of Arab origin, especially Iraqis".

The British Medical Association has become so concerned about the lethal potential of genetically based biological weapons that it has opened an investigation, which is due to report in January. Dr Vivienne Nathanson, who organised the research, said: "With an ethnically targeted weapon, you could even hit groups within a population. The history of warfare, in which many conflicts have an ethnic factor, shows us how dangerous this could be."

Genetic weapons to provide force for high-tech ethnic war
Jeremy Laurance Health Editor
2 July 1997
Vivienne Nathanson, head of science and ethics at the BMA, said: "It is clearly a very frightening scenario. We are trying to prevent new weapons being developed and distributed. We want to know whether genetic weapons are feasible and how to control or stop them." The investigation, commissioned by the association's board of science, was announced at the BMA's annual conference in Edinburgh. It is due for completion in 12 months. Scientists expect to be able to produce the first genetically targeted drugs in five years. The drugs would repair faulty DNA within the cell and might be used to treat conditions such as diabetes and cystic fibrosis. Dr Nathanson said: "No one has been able to tell me why, if we can produce genetically targeted drugs with a good effect, we won't be able to produce similar drugs with a bad effect in the same time-scale."
The Human Genome Project, which is mapping the entire human genetic code, might produce enough information to allow specific genetic types to be identified. "We know the genes for hair colour, eye colour and height. If 90 per cent of the [enemy] have blue eyes, blond hair and are over six feet tall, that could be the cluster you are looking for." Certain blood types were commoner in different ethnic groups and could also be targeted, she said.

US Special Forces Seek Genetically Engineered Bioweapons
(Austin and Hamburg, 12 August 2002) - The US Special Forces have issued a brief but explicit request for US scientists to make proposals to create genetically engineered offensive biological weapons. This is the fourth US government proposal for anti-material biological weapons uncovered by the Sunshine Project this year. All biological weapons are prohibited by the Biological and Toxin Weapons Convention (BTWC), which the United States is legally obliged to obey.

Despite last year's anthrax attacks and US pledges of robust retaliation against bioweapons violators, in 2002, the US Special Forces asked US scientists to create bioweapons for use in covert military operations. Like all bioweapons these violate the BTWC, and because the Special Forces are requesting US scientists to make them, the elite military group is flirting dangerously with the Biological Weapons Anti-Terrorism Act, a US law that makes solicitation of bioweaponeering a criminal act.

The Special Forces Request
The US Special Forces' solicitation came in January 2002 as part of "Scientists Helping America", a cooperative effort between the Special Forces, the Defense Advanced Research Projects Agency (DARPA), and the US Naval Research Laboratory (NRL). Playing heavily on the US reaction to the September 11th attacks, "Scientists Helping America" asked researchers to show their patriotism by turning their talents to weapons, including bioweapons, specifically, genetically engineered bugs that eat materials and stealthy modified organisms (called "taggants") that can be used to invisibly "paint" a target so that it can be destroyed with other weapons later.

The Special Forces desire was initially identified in a short May 1999 document by its Future Technology Working Group. The document identifies the military appeal of "a bio-engineered organism [that] can become a weapon by acting as a corrosive agent after a certain period of time or by a remote command". The same document sets out the uses of a "bio-organism that can be placed on a building and then grow across that building to act as an illuminator for target identification, or precision attacks" (taggants). The document indicates that these bioweapons would be used covertly, stipulating that they "should be innocuous in appearance so that they can be carried and placed by Special Operations Forces without detection."

Following the May 1999 paper, the March 2001 report Special Operations Technology Objectives provided an overview of the wide range of military technologies required by the Special Forces. This report includes descriptions of many military technologies and reiterates the request for genetically modified anti-material bioweapons and taggant bioweapons. In January 2002, as part of "Scientists Helping America", the Special Forces posted the March 2001 report on the internet and requested US scientists to forward proposals to DARPA. In early 2002 DARPA vetted the ideas and invited the authors of promising proposals to come to Washington and present them to military officials. On 25 January 2002, the Sunshine Project requested these proposals from DARPA under the Freedom of Information Act. DARPA has not responded to the request.

Undermining Biosafety
Preventing genetically engineered disasters is a common concern of arms control and biosafety. The Special Forces propose to covertly introduce difficult to detect genetically modified organisms (GMOs) into third countries. The nascent international safety system for transboundary movement of GMOs (the Cartagena Biosafety Protocol) creates the fundamental requirement of consent. That is, deliberate introduction of GMOs into the environment must have the advanced informed agreement of a competent government agency in the receiving country which reviews the safety and desirability each new introduction on its soil. The Special Forces obviously will not seek permission from a country they are attacking. Moreover, the Special Forces have virtually no knowledge or ability to predict the ecological impacts of use of such environment modifying weapons. As such, the proposed weapons not only pose arms control problems; but are a direct affront to international biosafety efforts.

More US Bioweapons Proposals
The Special Forces are not the only US government agency playing with biological fire - several US Department of Defense agencies are failing to obey the Biological and Toxin Weapons Convention (BTWC). The Special Forces join the Naval Research Laboratory (Washington, DC), Brooks Air Force Base (San Antonio, TX), and the US Department of Energy's Idaho National Engineering Laboratory as proponents of US bioweapons production. In addition, the Joint Non-Lethal Weapons Directorate (JNLWD), run by the US Marine Corps, has requested the US National Academies of Science to assess proposals for anti-material biological weapons. Other JNLWD documents describe "calmative" drug weapons for crowd control that would also violate biological and chemical weapons law. The Sunshine Project has submitted these documents to the US Department of Justice and requested an investigation. To date, there has been no response. (See the Sunshine Project website, www.sunshine-project.org, for more information on the other cases.)